«

»

Listen: Can California Lower the Price of Insulin?

California Healthline senior correspondent Angela Hart appeared on KCRW’s “Press Play With Madeleine Brand” and KJZZ, a public radio station in Phoenix, this month to discuss California’s plan to reduce the cost of some prescription medications — starting with insulin — by diving into the generic drug market. California lawmakers set aside $100 million in the recently adopted 2022-23 state budget to help launch the CalRx drug label, and the state could start producing generic insulin within the next few years, according to Gov. Gavin Newsom’s administration. The goal is to make the drug available to millions of Californians via pharmacies, retail st...

Read the full post at Syndicate – Kaiser Health News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive